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Abstract
Rationale—There is substantial state-to-state heterogeneity in tuberculosis (TB) in the United 
States; better understanding this heterogeneity can inform effective response to TB at the state 
level, the level at which most TB control efforts are coordinated.
Objectives—To characterize drivers of state-level heterogeneity in TB epidemiology in the four 
U.S. states that bear half the country’s TB burden: California, Florida, New York, and Texas.
Methods—We constructed an individual-based model of TB in the four U.S. states and calibrated 
the model to state-specific demographic and age- and nativity-stratified TB incidence data. We 
used the model to infer differences in natural history of TB and in future projections of TB.
Measurements and Main Results—We found that differences in both demographic makeup 
(particularly the size and composition of the foreign-born population) and TB transmission 
dynamics contribute to state-level differences in TB epidemiology. The projected median annual 
rate of decline in TB incidence in the next decade was substantially higher in Texas (3.3%; 95% 
range, −5.6 to 10.9) than in California (1.7%; 95% range, −3.8 to 7.1), Florida (1.5%; 95% range, 
−7.4 to 14), and New York (1.9%; 95% range, −6.4 to 9.8). All scenarios projected a flattening of 
the decline in TB incidence by 2025 without additional resources or interventions.
Conclusions—There is substantial state-level heterogeneity in TB epidemiology in the four 
states, which reflect both demographic factors and potential differences in the natural history of 
TB. These differences may inform resource allocation decisions in these states.
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Tuberculosis disease (TB) remains an important public health concern in the United States, 
with 9,557 reported cases in 2015 (1). TB incidence declined from 9.7 per 100,000 in 1993 
to 3.0 in 2013 in the United States but remained essentially flat from 2013 to 2015 (1, 2). 
The leveling of TB incidence may represent statistical chance but may also reflect important 
underlying dynamics in the TB epidemic, such as the country’s changing demographic 
makeup or a plateau in current interventions’ achievable effect. Foreign-born individuals 
now account for two-thirds of new TB cases, with a TB incidence of 15.1 per 100,000/yr (2) 
and numbers that have increased from 7.9% of the U.S. population in 1990 to 13.2% in 2014 
(3). As such, it remains uncertain whether declines in TB incidence will continue in the 
absence of additional interventions (4).
Importantly, the TB epidemic in the United States is not homogeneous. States differ in their 
demographic makeup (particularly the size and origin of their foreign-born populations) and 
historical rates of TB, which may reflect differences in ongoing transmission (5), latent TB 
infection (LTBI) prevalence, and differential reactivation probabilities (e.g., due to 
differences in underlying risk factors) (6) as well as funding and implementation of TB 
prevention and control efforts. Such differences may result in heterogeneous trajectories of 
TB incidence in the future as well as different ideal strategies for TB prevention and control 
at the state level. For example, contact investigation may have greater epidemiological 
impact in areas with more ongoing transmission, whereas preventive therapy may be more 
important in areas with higher population-level risks of reactivation. TB control activities are 
largely planned and implemented at the state level, with funding from federal and state 
governments in the United States, allowing for implementation of state-specific TB control 
strategies. As different states seek to implement the strategies that will be most effective in 
eliminating TB in their specific contexts, therefore, it will become increasingly important to 
account for such heterogeneities at the state level (4).
To illustrate the importance of these heterogeneities and assist in state-level decision-
making, we constructed an individual-level model of TB, applied separately to the four 
states that report half of all incident TB cases in the United States: California, Florida, New 
York, and Texas. Our primary goals were (1) to characterize and quantify demographic and 
TB natural history mechanisms underlying state-level differences in TB epidemiology, and 
(2) to use this understanding to project state-specific TB incidence in the coming 10 years.
Methods
Overview
We developed an individual-based modeling framework structured to capture demographic 
and epidemiological processes generating underlying differences in TB epidemiology and 
applied this framework to four states: California, Florida, New York, and Texas. For each 
state, we investigated the demographic and epidemiologic parameters that best explained 
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state-level TB incidence. Then, using state-specific best-fit models, we projected TB 
incidence through 2025.
Demographic and TB Data
We obtained demographic data on population sizes and age-specific U.S.- and foreign-born 
populations for the four states from the 5-year estimates of the American Community 
Surveys of 2005 and 2014 (7, 8). We obtained U.S. TB case report data from the National 
TB Surveillance System, stratified by state, nativity, and age for the 5-year periods 1993 to 
1997, 2001 to 2005, and 2009 to 2013 using the Online Tuberculosis Information System 
data portal (9). We used these data to estimate the age- and state-specific TB incidence in the 
time periods 1993 to 1997, 2001 to 2005, and 2009 to 2013. These estimates served as 
calibration targets for the model, which aimed to capture both the historic trends in TB 
incidence and the distribution of TB by age and nativity. Due to the lack of American 
Community Surveys data for foreign-born 1993 to 1997 population estimates, we assumed 
that the proportion of the foreign-born population in each state was the same as in 2001 to 
2005.
Modeling Framework
We used an individual-based framework to model demographic processes, differences in 
natural history, and transmission dynamics of TB. We modeled each state-level population as 
having a constant per capita birth rate and age-specific mortality rates on the basis of the 
Siler mortality model (10) (see online supplement). Each individual was modeled as 
dwelling in and transitioning between four TB categories: (1) uninfected, (2) LTBI, (3) 
active TB disease, and (4) successfully treated TB disease (Figure 1). We assumed the model 
population to mix homogeneously. Hence, the hazard of TB infection changes over time but 
does not differ by age or nativity. State-specific transmission rates (i.e., the average number 
of individuals infected by an infectious case per year) were allowed to decline exponentially 
over time (i.e., constant annual percentage decline), and this rate of decline was allowed to 
change in 1993, when more detailed data became available. Individuals with LTBI 
experience an ongoing risk of developing TB disease. We modeled reactivation rates by 
adapting a formula proposed by Vynnycky and Fine (11), which assumes an exponential 
decline in reactivation with time since infection, coupled with an increase in reactivation 
with age. Individuals with TB disease, on receiving proper diagnosis and successful 
treatment, were assumed to become immediately noninfectious. Individuals with TB disease 
(without treatment) were also subject to TB-related mortality. Reinfection of individuals 
previously treated or currently infected was also allowed.
Immigration and Importation of TB
Immigration was modeled explicitly as a continuous rate of influx into the population, the 
rate of which was calibrated to the size of the foreign-born population in each state. To 
capture heterogeneities in global TB incidence, we modeled eight countries/regions of 
origin: (1) Mexico, (2) Latin America (excluding Mexico), (3) China, (4) India, (5) Asia 
(excluding China and India), (6) Africa, (7) Europe, and (8) others. Each individual was 
probabilistically assigned a TB status on arrival depending on age and nativity, under the 
assumption that the individual experienced a constant hazard of TB infection (consistent 
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with the prevalence in the region of origin; see Table E2 in the online supplement) from birth 
until arrival in the United States. The detailed models for immigration and importation of TB 
along with estimated age- and region-specific LTBI prevalence among foreign-born 
individuals are provided in the online supplement. We calibrated immigration rates from 
each region to fit the marginal distribution of the foreign-born population by age and region 
of origin (7, 8). The model-based simulations and demographic data are compared in Figure 
2.
Model Simulations
Each simulation consisted of two phases: (1) a “burn-in” phase (pre-1993), in which the 
model was run for 100 years with a decline in TB transmission rate to ensure a declining 
trend of TB transmission during this era and to reproduce observed trends in age-specific 
LTBI prevalence, and (2) the calibration phase (1993–2013), in which we fit a different 
annual decline in the TB transmission rate to recapitulate recent TB incidence trends.
Model Fitting
We used a likelihood-based method to calibrate each state-specific model to available data. 
We used a binomial likelihood function, fitting data to state- and age-specific TB incidence 
among U.S.- and foreign-born individuals, in three time periods: 1993 to 1997, 2001 to 
2005, and 2009 to 2013. For each state, we drew 200,000 different parameter combinations 
using Latin Hypercube sampling (12, 13) from the parameter ranges provided in Table E1. 
The single combination that yielded the highest likelihood (i.e., best fit to the data) was 
taken as the maximum likelihood estimate (MLE), which was then used as the baseline 
simulation for each state and compared with the MLE models of other states. Data and 
simulations from the MLE models are compared in Figure 3 and Figure E1.
Natural History Parameter Estimation
We used the MLE model in each state to infer two key parameters associated with the 
natural history of TB, namely the historical rate of decline in TB transmission rate and the 
reactivation rates among adults with LTBI. Estimates for each parameter value were 
achieved by constructing a likelihood profile that maximized the likelihood function over all 
parameters while holding the parameter being profiled constant. The 95% confidence 
interval (CI) was estimated for each parameter by finding the range of parameter values 
whose likelihood estimates were within 1.92 log-likelihood units, on the basis of univariate 
confidence limits using the χ2 distribution with 1 degree of freedom (14).
Model Projections
We generated MLE model projections for 12 years, from 2014 to 2025, to validate the 
models against existing data (2014–2015) and project future trends. The projections were 
based on continuation of current immigration trends (including both the rates of immigration 
and the composition of persons arriving in the United States by nativity) and continuing 
decline in transmission rates as estimated to be occurring currently. We conducted 100 
replicated simulations of the MLE model and estimated the median and 95% range of 
projected epidemiological parameters from the simulations.
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Results
State-Level Demography
Between 2009 and 2014, foreign-born individuals composed 27.1% of the population in 
California, 22.6% in New York, 20.0% in Florida, and 16.8% in Texas. The corresponding 
regions of origin differed substantially across the states (Figure 2). Mexico—with TB 
prevalence of 42 per 100,000 persons in 2000 (15)—contributed a large percentage of the 
foreign born in Texas (56.1%) and California (40.8%) but not in Florida (7.1%) or New York 
(5.6%). Asian countries (TB prevalence in 2000 of 170 per 100,000 in China, 438 in India, 
and between 425-515 elsewhere [15]) accounted for 37.8% of the foreign born in California, 
28.3% in New York, 20.2% in Texas, and only 10.6% in Florida. Latin America (excluding 
Mexico), with TB prevalence between 59 and 138 per 100,000 in 2000 (15), represented 
68.0% of the foreign born in Florida (primarily from Cuba) and 43.8% in New York but only 
small percentages in California and Texas.
TB Incidence
Reported mean annual TB incidence between 2009 and 2013 was 5.9 per 100,000 persons in 
California, 3.8 in Florida, 4.6 in New York, and 4.7 in Texas. In comparison, the median 
(and 95% range) value across model simulations for the mean annual TB incidence over the 
same time period was 6.7 (5.3–8.0) in California, 3.9 (2.7–5.2) in Florida, 5.1 (3.9–6.5) in 
New York, and 4.7 (3.6–6.5) in Texas (Figure 3). Among U.S.-born individuals, reported 
annual TB incidence was relatively higher in Texas (2.7) compared with New York (1.3), 
California (1.8), and Florida (2.3). Corresponding model estimates were 2.4 (1.5–3.8) in 
Texas, compared with 1.9 (1.1–2.8) in New York, 1.8 (1–2.7) in California, and 2.2 (1.5–3.1) 
in Florida. Among foreign born individuals, reported TB incidence was lowest in Florida 
(9.5, vs. 15.8–16.9 in the other three states); this trend was also reflected in model estimates 
(11.1 in Florida; 95% range, 6.27–14.1; vs. 16.3–19.6 in the other three states). Comparisons 
of age-specific TB incidence among U.S.- and foreign-born persons between 2009 and 2013 
are shown in Figure 3.
The models fit age- and nativity-specific reported TB incidence rates well from 2009 to 
2013 (Figure 3, hatched vs. solid bars). This was also generally true for comparisons in 1993 
to 1997 and 2001 to 2005 (Figure E2), with a few exceptions, such as underestimation of TB 
incidence among the foreign born in 1993 to 1997 in California (Figure E2, top left). 
Between 1993 and 2013 (Table 1), the model estimated an annual decline in TB incidence of 
4.7% (95% range, 1.9–7.7%) in California (actual decline, 5.3%), 6.1% (2.5–9.9%) in 
Florida (actual decline, 6.3%), 7.0% (4.1–10.3%) in New York (actual decline, 7.8%) and 
5.8% (2.3–9.3%) in Texas (actual decline, 5.2%). The models were generally more accurate 
in reflecting recent data (2009–2013) than older data (1993-1997 and 2001–2005) (Figure 
4).
State-Level Differences in Natural History of TB
We used the model to infer state-level differences in the natural history of TB by estimating 
two major contributors to incidence, namely: (1) the annual decline in transmission rates, 
and (2) reactivation rates among adult individuals with remote LTBI. We estimated that TB 
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transmission rates have been declining in all states but at higher rates in California (11%/yr; 
95% CI, 5–13%) and New York (10%/yr; 95% CI, 9–15%) compared with Florida (6.8%/yr; 
95% CI, 0–9%) and Texas (5.5%/yr; 95% CI, 3–13%) (Figure 5). These declines in 
transmission rates and the state-level differences are also reflected in the trends of estimated 
proportions of TB cases due to recent transmission (Figure E4): the percentage of TB cases 
due to recent transmission was estimated in 2013 to be between 10 and 20% in California 
and New York, compared with around 30% in Florida. In Texas, the decline in recent 
transmission was low (4.5%/yr), with a 95% CI that included zero (0–16%). In addition, we 
estimated the reactivation rates among adults with remote LTBI in California (0.046 per 100 
person-years), Florida (0.037), and New York (0.036) to be lower than in Texas (0.058), 
although the CIs for all state-specific estimates overlapped (Figure 6).
Projections of Future TB Incidence
Between 2015 and 2025, the projected median annual rates of decline in overall TB 
incidence were 1.7% per year (95% range, 3.8% increase to 7.1%) in California, 1.5% (95% 
range, 7.4% increase to 14%) in Florida, 1.9% (95% range, 6.4% increase to 9.8%) in New 
York, and 3.3% (95% range, 5.6% increase to 10.9%) in Texas. The projected future rates of 
decline were substantially smaller than historical annual declines (reported above and in 
Table 1), although the confidence intervals did include sustained declines for all states. The 
rates of decline among U.S.-born persons were projected to be almost half those observed 
during the past 2 decades in California, Florida, and New York, whereas in Texas the 
projected decline at 6.5% per year was close to past levels. These projections were 
reasonably robust to uncertainty in parameter estimates (Figure E5).
Discussion
These individual-based models of TB transmission in the four states contributing more than 
half of U.S. incident TB highlight important differences in state-level TB dynamics. 
Specifically, differences in demography (especially of the foreign-born population) may 
contribute to much of the state-level heterogeneity in observed TB incidence. However, 
state-level differences in TB dynamics and natural history also play an important role, 
generating heterogeneities in the projected trajectories of TB incidence. Importantly, this 
model predicts a flattening of the decline in TB incidence in the coming decade in all four 
states unless additional resources or interventions are devoted to TB control. These findings 
illustrate the existence of state-level heterogeneity in TB dynamics and may help to frame 
plans to achieve TB elimination at the state level.
This modeling work illustrates that the natural history of TB may differ on the state level, 
perhaps reflecting the dynamics of migration and history of TB in each state. For example, 
we estimated that TB transmission was declining slowly, and reactivation remaining high, in 
Texas relative to other states. This may reflect that the majority of TB in Texas occurs in the 
Mexican-born population, which may spend relatively more ongoing time in their country of 
origin (i.e., with greater TB exposure) than persons from other countries who have traveled 
farther distances and subsequently do not visit those countries often. By contrast, the decline 
in TB transmission was most prominent in New York, which may reflect the large drop in 
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TB incidence (particularly among U.S.-born individuals through concerted TB control 
efforts) between 1993 and 2013 after the surge in TB incidence associated with HIV in the 
late 1980s (16). Large declines in transmission rates over the last 2 decades, ironically, lead 
to lower projected declines in TB incidence in the future, as there is not much ongoing 
transmission to halt, and the vast majority of TB incidence begins to reflect reactivation of 
LTBI among persons (mostly foreign born) who were likely infected in their countries of 
origin.
Our estimates of recent TB transmission within U.S. borders (between about 15% of all TB 
cases in California to 30% in Florida and Texas; Figure E4) are in line with genotype-based 
estimates of the fraction of TB cases that reflect recent transmission (as opposed to 
reactivation), which are as low as 15% (17). Our inferred reactivation rates in individuals 
with remote LTBI (0.03–0.06 per 100 person-years; Figure 6) are in line with findings of 
persistent reactivation among long-term immigrants to the United States (18, 19) and similar 
to some published estimates of reactivation risk (20), although lower than others (6).
Although a number of influential modeling works have elucidated various important facets 
of TB epidemiology (21–24), only a few have focused on the role of immigration (4, 25–27). 
These latter studies have also highlighted some of the challenges associated with achieving 
persistent declines in TB incidence and reaching elimination goals in settings where a 
significant fraction of the TB cases are a result of reactivation of latent infection and 
imported into the population via immigration. Our model differs from these previous models 
in that we use an individual-based framework and evaluate state-level heterogeneities in TB 
transmission. Our model structure allows incorporation of novel details, including the 
demographic composition of a foreign-born population by age and region of origin, declines 
in reactivation rates from time of infection, and use of a likelihood-based approach to draw 
inference on the values of natural history parameters from a population perspective. In the 
same vein, this flexible structure also allows for incorporating targeted interventions (such as 
providing LTBI testing and treatment to key populations on the basis of age, nativity, or 
other risk factors) at the state level in the future. Finally, because our approach relies on 
applying a uniform model structure and model calibration protocols across the states 
(including data, which are available for all 50 states), this approach can be readily applied to 
other states to project TB incidence for subpopulations in their states as well as plan for and 
implement interventions to accelerate TB elimination. In the future, by incorporating more 
detailed data on TB in high-risk populations, state-level TB control efforts, and immigration 
patterns, this model can be used to evaluate key TB interventions—including enhanced 
contact investigation and targeted testing and treatment of high-risk populations—at the state 
level. Costs can also be incorporated to evaluate budget impact and cost effectiveness.
As with any modeling study, we made several simplifying assumptions. First, in the absence 
of data to inform quantitative estimates, we assumed no difference between foreign-born and 
U.S.-born individuals in terms of TB transmission rates, respiratory mixing patterns, natural 
history of TB (6), or treatment-seeking behavior. Importantly, sensitivity analyses (Figures 
E6–E8) suggest that most of our primary results are not drastically affected by 
heterogeneous mixing (e.g., closer mixing of the foreign born with each other than with the 
U.S. born). We assumed that immigrating foreign-born individuals are representative of the 
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population of the region where they are born, in terms of LTBI prevalence. However, 
documented immigrants often have substantially lower TB risk than individuals in their 
home countries (18), whereas refugees and undocumented individuals may have higher 
prevalence of TB or LTBI. We also did not model secular trends in reactivation rates; 
although there may have been decreases in reactivation rates over longer time periods (20), 
these trends may be less important over the 30-year calibration and projection period in this 
model. Our model did not capture several factors that can drive population heterogeneity in 
the risk of TB, such as the prevalence of HIV, drug-resistant TB, homelessness, and 
incarceration. Although on a population level none of these factors individually is more than 
10% prevalent among patients with TB nationwide, the combination of these factors may 
influence trends in TB incidence. The model also did not account for within-state 
geographic heterogeneity, which is difficult to uniformly incorporate using a common 
structure for all states. Finally, in making future projections, we did not account for state-
specific accelerations in TB programmatic efforts to target, test, and treat populations at risk 
for TB or LTBI or for potential future demographic changes, such as an increase in the size 
of the foreign-born population or potential decline in TB prevalence globally (28). As such, 
these projections should be taken with caution, illustrating only the likely future trends in 
TB incidence if demographics and global TB burden remain relatively constant.
Our modeling was also limited by unavailability of data. State-level demographic data 
obtained from the American Community Survey were only available starting in 2005; hence, 
we were not able to capture historical trends in immigration with similar quality. Other data 
that may also improve future modeling efforts include state-level prevalence estimates of 
LTBI (currently available only at the national level [29]), LTBI prevalence among those born 
in key countries, state-level estimates of the proportion of incident TB reflecting recent 
transmission, and state-level data on TB control and care (e.g., LTBI testing and treatment 
and contact investigation).
In summary, this modeling work reveals important differences in the population-level 
dynamics of TB at the state level. These differences reflect both demographic factors 
(particularly the historical size and makeup of the foreign-born population) and potential 
differences in the natural history of TB, as reflected in the rates of transmission and 
reactivation. Our findings illustrate that the mechanisms underlying TB epidemiology, as 
well as the future trajectory of TB in the absence of additional intervention, may differ 
substantially from one state to the next. Ultimately, if TB is to be eliminated in the United 
States, a one-size-fits-all approach is unlikely to be effective.
Supplementary Material
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At a Glance Commentary
Scientific Knowledge on the Subject
Model-based understanding of tuberculosis (TB) epidemiological dynamics is limited; 
previous works have not accounted for (1) trends in mechanistic drivers (e.g., 
immigration, and reactivation rates), and (2) geographical heterogeneity in potential 
drivers of TB, such as demographic makeup and historical TB dynamics. Better 
understanding the heterogeneity (along with the drivers) can inform effective state-level 
responses to TB.
What This Study Adds to the Field
We constructed an individual-based model of TB in the four U.S. states that bear half of 
the country’s TB burden—California, Florida, New York, and Texas—and calibrated the 
model to state-specific demographic, and age- and nativity-stratified TB incidence data. 
We used the model to infer differences in natural history of TB and in future projections 
of TB. We find that there is substantial state-level heterogeneity in TB in the United 
States, which reflect both demographic factors and potential differences in the natural 
history of TB. These heterogeneities can affect projections of TB incidence and the 
epidemiological impact of TB interventions.
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Figure 1. 
Schematic representation of the modeling framework. (A) Natural history of tuberculosis 
(TB) was captured in this framework by individual transitions between the four stages: 
uninfected, latent TB infection (LTBI), active TB, and after treatment. Individuals are born 
uninfected and acquire LTBI at a rate commensurate with the local force of infection. 
Individuals with LTBI reactivate to develop active TB disease, at a rate reflecting both age 
and time since infection. On receiving successful treatment, an individual progresses to the 
post-treatment stage. Both individuals with LTBI and treated individuals can be reinfected; 
individuals with previous history of TB are modeled to have partial protection against 
reinfection. (B) The reactivation rate among individuals with LTBI was modeled to decline 
continuously over time: the further away an individual is from the time of infection, the 
smaller the rate. Reactivation rates are also assumed to increase with age (not shown in this 
illustration; see online supplement for details). (C) Immigration was modeled as importation 
of individuals from one of the eight regions as described in METHODS. The region-specific 
size of the immigrant population varied by state. Individuals arriving to the United States 
were apportioned as uninfected, LTBI, or TB at arrival according to the TB prevalence in the 
region of origin.
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Figure 2. 
Comparisons of state-level demographic data and model simulations. For each of the four 
states (California, Florida, New York, and Texas), the pie charts show the size of the 
population that are U.S. (in light blue) and foreign (in pink) born, and their further 
subdivisions by eight regions: (1) Mexico, (2) Americas excluding Mexico and Canada, (3) 
China, (4) India, (5) Asia excluding China and India, (6) Africa, (7) Europe, and (8) rest of 
the world. The horizontal bars show the distribution of the population (light blue showing 
U.S. born, and pink showing foreign born) by age categories indicated on the side. The data 
(solid bars) are obtained from 5-year estimates (2009–2014) of the American Community 
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Survey. Shown in hatched bars are the distributions in simulations of the calibrated models 
for each of the states.
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Figure 3. 
Reported and model-based estimates of annual tuberculosis (TB) incidence from 2009 to 
2013, by age and origin (U.S. vs. foreign born) for each of the four states. The bar charts 
show TB incidence in California, Florida, New York, and Texas (from left to right), for the 
5-year time period spanning 2009 to 2013. TB incidence is categorized by age in four 
categories (labeled at the bottom) and country of origin (U.S. born in light blue and foreign 
born in pink). The solid bars show reported data: TB case report data were obtained from 
Online Tuberculosis Information System (OTIS) data repository (9), and data on 
demographics were obtained from the American Community Survey (8). The hatched bars 
show model-based estimates: shown are medians (and 95% range) in 100 replicated 
simulations of the model, with maximum-likelihood estimates for each of the four states.
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Figure 4. 
Model-based simulations and projections of trends in tuberculosis (TB) incidence in four 
states. Shown are model-based simulations in trends of TB incidence between 1993 and 
2013 followed by projections up to 2025 for each of four states: California (top left), Florida 
(top right), New York (bottom left), and Texas (bottom right). The simulations are based on 
the state-specific maximum likelihood estimate (MLE) models, and projections are the 
continuation of model simulations (with continued decline in the transmission rates at the 
post-1993 estimate). For each panel, shown are medians (solid lines) and interquartile range 
(shaded area) of 100 replicate simulations of the MLE models. Shown in black dots are data 
for annual TB incidence between 1993 and 2015. Shown in dashed lines is the estimated 
mean annual TB incidence (based on data) in each state in three 5-year periods of 1993 to 
1997, 2001 to 2005, and 2009 to 2013. The foreign-born population is represented in pink, 
U.S.-born population in light blue, and the total population in gray.
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Figure 5. 
Estimated annual declines in tuberculosis transmission rates. Likelihood profiles (shown in a 
log scale as a difference with Δloglik = 0 representing the estimated 95% threshold) for the 
annual rates of decline in the transmission rate (in %/yr) in the four states: California (top 
left), Florida (top right), New York (bottom left), and Texas (bottom right). Each point on the 
profile represents the log-likelihood of each estimate (on the y-axis) maximized over all 
parameters with the decline in transmission held at the level on the x-axis. The point marked 
with an open circle shows the maximum likelihood estimate (MLE), and the two dashed 
vertical lines show the estimated 95% confidence interval (smoothed estimate of log-
likelihood no lower than 1.92 less than the MLE). loglik = log-likelihood.
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Figure 6. 
Estimated annual declines in tuberculosis reactivation rates. Likelihood profiles (shown in a 
log scale as a difference with Δloglik = 0 representing the estimated 95% threshold) for 
reactivation rate in the four states: California (top left), Florida (top right), New York 
(bottom left), and Texas (bottom right). The point marked with an open circle shows the 
maximum likelihood estimate, and the two dashed vertical lines show the estimated 95% 
confidence interval. loglik = log-likelihood.
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Table 1
Annual Tuberculosis Incidence and Annual Percentage Declines, Comparing Reported Data with Model 
Simulations
California Florida New York Texas
1993, annual TB incidence per 100,000 persons
 Data 16.4 11.8 21 13
 Model 15.4 (9.9 to 20.4) 11.9 (7.0 to 17.4) 19.1 (13.7 to 27.1) 13.4 (9.5 to 19.7)
2013, annual TB incidence per 100,000 persons
 Data 5.7 3.3 4.4 4.6
 Model 6.0 (3.8 to 9.0) 3.3 (1.9 to 5.7) 4.8 (2.9 to 7.3) 4.2 (2.5 to 6.8)
1993–2013, annual decline in TB incidence, %
 Data 5.3% 6.3% 7.8% 5.2%
 Model 4.7% (1.9 to 7.7) 6.1% (2.5 to 9.9) 7.0% (4.1 to 10.3) 5.8% (2.3 to 9.3)
2025, annual TB incidence per 100,000 persons
 Model 5.2 (2.9 to 7.1) 2.5 (0.9 to 4.5) 3.6 (1.8 to 5.5) 2.9 (1.3 to 5.5)
2015–2025, annual decline in TB incidence, %
 Model 1.7% (−3.8* to 7.1) 1.5% (−7.4* to 14.0) 1.9% (−6.4* to 9.8) 3.3% (−5.6* to 10.9)
Definition of abbreviation: TB = tuberculosis.
Model estimates are based on the maximum likelihood estimate model and are presented as median (2.5 to 97.5 percentile) estimates.
*Negative values indicate increases.
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